HALOZYME THERAPEUTICS INC
HALO·40637H109·US·Common Stock·Healthcare - Biotechnology-13D/G
HALO (HALOZYME THERAPEUTICS INC) is held by 233 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1B), VANGUARD CAPITAL MANAGEMENT LLC ($418.8M), VANGUARD PORTFOLIO MANAGEMENT LLC ($414.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 121 funds bought HALO.
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 19, 2026 · Activists Apr 30, 2026 · Congress Apr 7, 2026
Top Holders
Showing 1-20 of 252
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer